glp 1 with crohn's disease Relevance of Glucagon-Like Peptide (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review GLP-1 Medications: Reimagining the Treatment
Description
Medication persistence, or remaining on a medication as prescribed, is crucial for meaningful obesity management outcomes.

Therefore, there is a need to identify those potential changes and adjust patients medication doses in order to achieve higher efficacy and avoid toxicity.

Learn how GLP-1 side effects like body odor, sweat, and skin changes show up, plus gentle ways to manage Ozempic and Wegovy body odor and irritation.

Among the mechanisms, our research group and others have demonstrated that the gut microbiota fermentation (i.e., bacterial digestion of specific compounds) of specific prebiotics or other non-digestible carbohydrates is associated with the secretion of enteroendocrine peptides, such as the glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), produced by L-cells
